OptimizeRx Corporation
OPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $89 | $245 | $299 | $1,070 |
| - Cash | $13 | $14 | $18 | $85 |
| + Debt | $33 | $37 | $0 | $0 |
| Enterprise Value | $109 | $268 | $281 | $986 |
| Revenue | $92 | $72 | $62 | $61 |
| % Growth | 28.8% | 14.5% | 1.9% | – |
| Gross Profit | $59 | $43 | $39 | $36 |
| % Margin | 64.5% | 60% | 62.4% | 58.1% |
| EBITDA | -$9 | -$21 | -$9 | $2 |
| % Margin | -9.7% | -29.8% | -15.1% | 3.8% |
| Net Income | -$20 | -$18 | -$11 | $0 |
| % Margin | -21.8% | -24.6% | -18.3% | 0.6% |
| EPS Diluted | -1.1 | -1.03 | -0.64 | 0.021 |
| % Growth | -6.8% | -60.9% | -3,090.7% | – |
| Operating Cash Flow | $5 | -$7 | $11 | $1 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | $5 | -$8 | $10 | $0 |